Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Moore

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Irish Medical Journal|July 9, 2011
Exercise induced fatigue: unfit or unwell?D M Moore, P Nadarajan, R Hawksworth, et al.
Journal of Virology|May 1, 1989
Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virusB Baxt, V Vakharia, D M Moore, et al.
American Journal of Otolaryngology|May 1, 1989
Effect of superior laryngeal nerve stimulation on phonation in an in vivo canine modelG S Berke, D M Moore, B R Gerratt, et al.
Current Medical Research and Opinion|January 1, 1978
Bromocriptine in the treatment of secondary amenorrhoea and ovarian dysfunction in hyper- and normo-prolactinaemic patientsM P Milligan, D M Moore, M M Singh, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|July 12, 2021
Good mid- to long-term results of the cemented oxford phase 3 unicompartmental knee arthroplasty in a non-designer centreD M Moore, G A Sheridan, A Welch-Phillips, et al.
Diabetes|February 1, 1994
Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymphR A Poulin, G M Steil, D M Moore, et al.
Lancet (London, England)|December 9, 1978
Serum-prolactin in female infertilityD M Moore, M M Singh, M S Buckingham, et al.
Biochemistry|December 18, 1984
Purification and immunogenicity of fusion VP1 protein of foot and mouth disease virusS J Shire, L Bock, J Ogez, et al.
Journal of Virology|May 1, 1984
Biochemical map of polypeptides specified by foot-and-mouth disease virusM J Grubman, B H Robertson, D O Morgan, et al.
Journal of Virology|May 1, 1991
Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variantsJ C Saiz, M J Gonzalez, M V Borca, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Irish Medical Journal|July 9, 2011
Exercise induced fatigue: unfit or unwell?D M Moore, P Nadarajan, R Hawksworth, et al.
Journal of Virology|May 1, 1989
Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virusB Baxt, V Vakharia, D M Moore, et al.
American Journal of Otolaryngology|May 1, 1989
Effect of superior laryngeal nerve stimulation on phonation in an in vivo canine modelG S Berke, D M Moore, B R Gerratt, et al.
Current Medical Research and Opinion|January 1, 1978
Bromocriptine in the treatment of secondary amenorrhoea and ovarian dysfunction in hyper- and normo-prolactinaemic patientsM P Milligan, D M Moore, M M Singh, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|July 12, 2021
Good mid- to long-term results of the cemented oxford phase 3 unicompartmental knee arthroplasty in a non-designer centreD M Moore, G A Sheridan, A Welch-Phillips, et al.
Diabetes|February 1, 1994
Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymphR A Poulin, G M Steil, D M Moore, et al.
Lancet (London, England)|December 9, 1978
Serum-prolactin in female infertilityD M Moore, M M Singh, M S Buckingham, et al.
Biochemistry|December 18, 1984
Purification and immunogenicity of fusion VP1 protein of foot and mouth disease virusS J Shire, L Bock, J Ogez, et al.
Journal of Virology|May 1, 1984
Biochemical map of polypeptides specified by foot-and-mouth disease virusM J Grubman, B H Robertson, D O Morgan, et al.
Journal of Virology|May 1, 1991
Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variantsJ C Saiz, M J Gonzalez, M V Borca, et al.
Pageof 13